Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2023-03-07 00:00:00 ET · period of report 2023-03-04 · accession 0001765581-23-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-07 | 2023-03-04 | JAZZ | Mulligan Seamus | Dir | M - OptEx | $59.13 | +4,500 | 1.16M | +0.4% | +$266.1K |
| D | 2023-03-07 | 2023-03-04 | JAZZ | Mulligan Seamus | Dir | M - OptEx | $0.00 | -4,500 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2023-03-04 | M | A | 4,500 | $59.13 | 1,164,800 | D | — | — | |
| 2 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-03-04 | M | D | 4,500 | $0.00 | 0 | D | $59.13 · — to 2023-03-04 | 4,500 Ordinary Shares | (F1) The option was granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Option Plan and vested in 12 monthly installments over one year from the grant date, March 5, 2013. |